Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis
Author:
Heinz WJ, Egerer G, Lellek H, Boehme A, Greiner J
Date: 12 December 2012
Abstract:
Invasive aspergillosis is an important cause of morbidity and mortality in haematological patients. Current guidelines recommend voriconazole as first-line therapy. A change in class of antifungal agent is generally recommended for salvage therapy. The focus of this analysis was to assess if posaconazole is suitable for salvage therapy following voriconazole treatment. This was a retrospective investigation on patients with sequential antifungal therapy of posaconazole after voriconazole identified at four German hospitals. Response rates at 30 and 60à¢â‚¬Æ’days following start of posaconazole application and toxicity of azoles by comparing liver enzymes and cholestasis parameters were evaluated. Data were analysed by descriptive statistics. Overall, the success rate was 72.2% [15 of 36 patients showed complete response (41.7%), 11 patients partial response (30.6%) at any time point], eight patients failed treatment and two were not evaluable. Mean laboratory values increased during voriconazole and decreased during posaconazole treatment: aspartate aminotransferase (increase: 31.9à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) vs. decrease: 19.6à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) ), alanine aminotransferase (32.4à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) vs. 19.8à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) ), gamma-glutamyl transferase (124.2à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) vs. 152.3à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) ) and alkaline phosphatase (71.5à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) vs. 40.3à¢â‚¬Æ’Uà¢â‚¬Æ’l(-1) ) respectively. No patient discontinued posaconazole therapy due to an adverse event. In this analysis posaconazole was a safe and effective antifungal salvage therapy in patients with prior administration of another triazole.à‚© 2012 Blackwell Verlag GmbH.
Download the full article (Disclaimer)
This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.